Exelixis
EXEL
#1626
Rank
ยฃ10.22 B
Marketcap
ยฃ41.27
Share price
-1.09%
Change (1 day)
45.36%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Quarterly Reports

Thumbnail Exelixis Quarterly Report 2026-q2

Quarterly Report 2026-q2

Language: English

View Quarterly Report
Thumbnail Exelixis Quarterly Report 2026-q1

Quarterly Report 2026-q1

Language: English

View Quarterly Report
Thumbnail Exelixis Quarterly Report 2025-q3

Quarterly Report 2025-q3

Language: English

View Quarterly Report
Thumbnail Exelixis Quarterly Report 2025-q2

Quarterly Report 2025-q2

Language: English

View Quarterly Report
Thumbnail Exelixis Quarterly Report 2025-q1

Quarterly Report 2025-q1

Language: English

View Quarterly Report